MQS Management LLC Makes New Investment in Prestige Consumer Healthcare Inc. (NYSE:PBH)

MQS Management LLC purchased a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 7,659 shares of the company’s stock, valued at approximately $552,000.

A number of other large investors have also recently added to or reduced their stakes in the business. State Board of Administration of Florida Retirement System increased its position in shares of Prestige Consumer Healthcare by 77.4% during the first quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock valued at $1,830,000 after acquiring an additional 11,000 shares during the last quarter. Lombard Odier Asset Management USA Corp purchased a new position in shares of Prestige Consumer Healthcare during the second quarter worth $550,000. CANADA LIFE ASSURANCE Co grew its stake in shares of Prestige Consumer Healthcare by 19.4% in the first quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company’s stock valued at $3,453,000 after buying an additional 7,715 shares in the last quarter. Sequoia Financial Advisors LLC grew its stake in shares of Prestige Consumer Healthcare by 12.9% in the third quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock valued at $708,000 after buying an additional 1,120 shares in the last quarter. Finally, Atria Investments Inc purchased a new stake in shares of Prestige Consumer Healthcare in the 1st quarter valued at $1,246,000. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on PBH shares. Jefferies Financial Group reaffirmed a “hold” rating and issued a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. DA Davidson reiterated a “buy” rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a report on Monday. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $94.20.

Prestige Consumer Healthcare Stock Up 0.8 %

Shares of Prestige Consumer Healthcare stock opened at $82.32 on Thursday. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. Prestige Consumer Healthcare Inc. has a 52-week low of $56.61 and a 52-week high of $83.13. The company has a market capitalization of $4.07 billion, a P/E ratio of 20.03, a P/E/G ratio of 2.30 and a beta of 0.47. The company has a 50 day moving average of $72.84 and a 200 day moving average of $70.00.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.09. The business had revenue of $283.79 million during the quarter, compared to analysts’ expectations of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. During the same period in the previous year, the company earned $1.07 EPS. The company’s revenue for the quarter was down .9% on a year-over-year basis. As a group, research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.45 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.